Ghassan Abou-Alfa, MD – HIMALAYA Phase III trial – Tremelimumab accepted under Priority Review in the US for patients with unresectable liver cancer in combination with Imfinzi.m4v Liver 3 Mins Read1 Dr. Ghassan Abu Alfa, MD with Memorial Sloan Kettering Cancer Center in New York, provides an update on the key…
Colon Cancer Treatment Adjuvant Therapy With Encorafenib and Cetuximab vs SOC Colorectal 3 Mins Read19 Rona Yaeger, MD, an eminent oncologist from Memorial Sloan Kettering Cancer Center, is currently involved in a significant clinical trial…
Where do Anti-TROP2 ADCs Factor into Advanced TNBC Care? Breast 1 Min Read0 Dive into additional groundbreaking treatment approaches for triple-negative breast cancer (TNBC) in this tumor board, the second in a series…
